All Clinical Trials

Clinical Trial NCT02073409,NCT02419989

Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis.

  • ClinicalTrials.gov ID: NCT02073409,NCT02419989
  • Recruiting participants (Starts Apr. 1, 2018)
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: RAKSHA JAIN

objective

PaRT a / PReDiCT: The primary objective of PReDiCT is to implement a standardized approach to establishing a diagnosis of nTM disease. PaRT B / PaTienCe: The primary objective of PaTienCe is to implement a standardized approach to the treatment of nTM in CF patients with a diagnosis of nTM disease.

If you are interested in this clinical trial, please contact Osvaldo Cavazos on the Children’s Health Research Team.Call 214-645-8000Email